Nomura Holdings’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.9M Buy
285,040
+222,325
+355% +$15.5M 0.05% 273
2025
Q4
$4.16M Sell
62,715
-21,476
-26% -$1.39M 0.01% 837
2025
Q3
$5.67M Buy
+84,191
New +$6.66M 0.01% 721
2025
Q2
Sell
-15,396
Closed -$1.21M 1586
2025
Q1
$1.05M Sell
15,396
-33,857
-69% -$2.76M ﹤0.01% 1258
2024
Q4
$3.83M Buy
49,253
+11,492
+30% +$851K 0.01% 859
2024
Q3
$2.53M Sell
37,761
-13,609
-26% -$1.12M 0.01% 869
2024
Q2
$5.82M Buy
51,370
+45,751
+814% +$5.78M 0.01% 626
2024
Q1
$779K Sell
5,619
-32,314
-85% -$4.06M ﹤0.01% 1169
2023
Q4
$4.71M Buy
+37,933
New +$3.88M 0.01% 679
2023
Q3
Sell
-4,502
Closed -$579K 1446
2023
Q2
$579K Buy
+4,502
New +$545K ﹤0.01% 1030
2022
Q3
Sell
-1,924
Closed -$163K 1757
2022
Q2
$149K Sell
1,924
-4,672
-71% -$426K ﹤0.01% 1325
2022
Q1
$876K Sell
6,596
-159,480
-96% -$17.4M ﹤0.01% 1156
2021
Q4
$22.3M Buy
166,076
+83,352
+101% +$12M 0.06% 250
2021
Q3
$11.4M Buy
82,724
+74,948
+964% +$9.45M 0.03% 353
2021
Q2
$831K Sell
7,776
-80,604
-91% -$7.74M ﹤0.01% 1141
2021
Q1
$7.95M Buy
88,380
+62,824
+246% +$5.9M 0.02% 408
2020
Q4
$2.36M Sell
25,556
-18,012
-41% -$1.61M ﹤0.01% 795
2020
Q3
$4.48M Buy
43,568
+34,044
+357% +$3.56M 0.01% 487
2020
Q2
$965K Buy
+9,524
New +$852K ﹤0.01% 723
2020
Q1
Sell
-2,220
Closed -$121K 995
2019
Q4
$121K Buy
+2,220
New +$105K ﹤0.01% 1030
2019
Q3
Sell
-33,656
Closed -$1.27M 1232
2019
Q2
$1.27M Buy
33,656
+13,280
+65% +$417K 0.01% 774
2019
Q1
$586K Sell
20,376
-202,536
-91% -$7.12M ﹤0.01% 888
2018
Q4
$6.66M Buy
222,912
+37,128
+20% +$1.18M 0.02% 420
2018
Q3
$6.21M Buy
185,784
+173,236
+1,381% +$5.37M 0.02% 450
2018
Q2
$298K Buy
+12,548
New +$266K ﹤0.01% 1118
2018
Q1
Sell
-21,120
Closed -$303K 1490
2017
Q4
$303K Buy
+21,120
New +$275K ﹤0.01% 1406
2017
Q3
Sell
-14,312
Closed -$262K 1512
2017
Q2
$262K Buy
+14,312
New +$264K ﹤0.01% 1355
2015
Q4
Sell
-12,368
Closed -$267K 1898
2015
Q3
$267K Sell
12,368
-1,976
-14% -$44.1K ﹤0.01% 1244
2015
Q2
$287K Sell
14,344
-21,688
-60% -$381K ﹤0.01% 1472
2015
Q1
$560K Sell
36,032
-412
-1% -$6.22K ﹤0.01% 1036
2014
Q4
$502K Buy
+36,444
New +$446K ﹤0.01% 1632
2014
Q3
Sell
-300,252
Closed -$2.98M 2832
2014
Q2
$2.98M Buy
300,252
+231,264
+335% +$2.05M ﹤0.01% 930
2014
Q1
$718K Buy
68,988
+34,492
+100% +$357K ﹤0.01% 1608
2013
Q4
$306K Buy
+34,496
New +$273K ﹤0.01% 1533
2013
Q3
Sell
-57,452
Closed -$321K 2381
2013
Q2
$321K Buy
+57,452
New +$275K ﹤0.01% 1562

Other funds holding DXCM

Nomura Holdings's DXCM Position: Q1 2026 in Review

Nomura Holdings increased its DexCom (DXCM) stake by 355% in Q1 2026, buying an estimated $15.5M and bringing the position to 285,040 shares worth $17.9M. The position accounts for 0.05% of the portfolio, ranked #273.

Nomura Holdings first reported a position in DXCM in Q2 2013 and has held it in 35 quarters since. The position peaked at $22.3M in Q4 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Nomura Holdings held 285,040 shares of DexCom worth $17.9M as of Q1 2026.
  • Nomura Holdings bought 222,325 DexCom shares in Q1 2026, an estimated $15.5M.
  • DexCom made up 0.05% of Nomura Holdings's portfolio in Q1 2026, its #273 holding.
  • Nomura Holdings first reported a position in DexCom in Q2 2013 and has held it in 35 quarters since.
  • Nomura Holdings's DexCom position peaked at $22.3M in Q4 2021.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.